Sagittarius Life Science Corp (TPEX:3205)
51.20
+0.70 (1.39%)
Sep 19, 2025, 1:30 PM CST
Sagittarius Life Science Revenue
Sagittarius Life Science had revenue of 112.69M TWD in the quarter ending June 30, 2025, a decrease of -4.75%. This brings the company's revenue in the last twelve months to 446.03M, down -0.14% year-over-year. In the year 2024, Sagittarius Life Science had annual revenue of 467.75M with 6.20% growth.
Revenue (ttm)
446.03M
Revenue Growth
-0.14%
P/S Ratio
7.75
Revenue / Employee
3.98M
Employees
112
Market Cap
3.46B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 467.75M | 27.29M | 6.20% |
Dec 31, 2023 | 440.46M | -88.61M | -16.75% |
Dec 31, 2022 | 529.07M | -58.55M | -9.96% |
Dec 31, 2021 | 587.61M | 29.43M | 5.27% |
Dec 31, 2020 | 558.19M | 119.47M | 27.23% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lumosa Therapeutics | 37.25M |
Lotus Pharmaceutical | 19.12B |
Oneness Biotech | 112.57M |
Polaris Group | 64.02M |
Center Laboratories | 1.60B |